Silence Therapeutics (SLN) Intangibles (2018 - 2026)
Silence Therapeutics (SLN) reported Intangibles of $248000.0 for Q1 2026, down 20.0% on a YoY basis from $310000.0 in Q1 2025, and down 13.89% sequentially from $288000.0 in Q4 2025.
Silence Therapeutics (SLN) Intangibles (2018 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 9 years of Intangibles data on file, last reported at $248000.0 in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 20.0% year-over-year to $248000.0; the trailing twelve-month figure through Mar 2026 stood at $248000.0 (down 20.0% YoY), and the FY2025 full-year result was $288000.0, down 7.69% from the prior year.
- Intangibles slipped to $248000.0 in Q1 2026, from $288000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $375337.1 in Q4 2022 to a low of $248000.0 in Q1 2026.
- A 5-year average of $312853.0 and a median of $311000.0 in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles jumped 114.18% in 2022 and decreased 20.0% in 2026, its largest moves.
- Tracing SLN's Intangibles over 5 years: stood at $375337.1 in 2022, then decreased by 6.09% to $352487.1 in 2023, then slipped by 11.49% to $312000.0 in 2024, then fell by 7.69% to $288000.0 in 2025, then retreated by 13.89% to $248000.0 in 2026.
- Business Quant data shows SLN's Intangibles at $248000.0 in Q1 2026, $288000.0 in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | 248,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 248,000.00 |
| Dec 31, 2025 | 288,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Mar 31, 2025 | 310,000.00 |
| Dec 31, 2024 | 312,000.00 |
| Dec 31, 2023 | 352,487.14 |
| Dec 31, 2022 | 375,337.06 |
| Dec 31, 2021 | 175,241.38 |
| Dec 31, 2020 | 118,840.59 |
| Dec 31, 2019 | 131,143.94 |
| Dec 31, 2018 | 82,353.10 |